Lymphoma - Hodgkin - Childhood

लिम्फोमा कैंसर ।मेरी नज़र से । एपिसोड -11 । डॉ जमाल ए खान | Lymphoma Cancer
लिम्फोमा कैंसर ।मेरी नज़र से । एपिसोड -11 । डॉ जमाल ए खान | Lymphoma Cancer administrator 2 Views • 2 years ago

Dr Jamal A. Khan is a pioneer in cancer immunotherapy in India, with over 17 years of exclusive clinical experience in dendritic cell therapy. His work on dendritic cell therapy in treating cancer is unparalleled in India.
Visit
www.denvax.in for more information

In this video dr. Jamal sharing his views on lymphoma cancer (Causes, Symptoms, Diagnosis, Treatment)



#lymphoma cancer #lymphoma cancer Treatment #lymphoma Cancer symptoms #Dr jamal A Khan #Denvax #hodgkins lymphoma #chemotherapy #Radiation #Cancer immunotherapy #Dendritic Cell Therapy

Comment: New PD-1 checkpoint inhibitors for treating Hodgkin lymphoma
Comment: New PD-1 checkpoint inhibitors for treating Hodgkin lymphoma administrator 4 Views • 2 years ago

Visit http://www.ecancer.org for more.

Dr Bollard talks to ecancertv at ASH 2014 about key abstracts highlighted by the conference and their implications for the field.

She comments first on the use of checkpoint inhibitors to manipulate the PD-1 pathway, touching first on Professor Armand's work with nivolumab and then Professor Moskowitz's study on pembrolizumab, both of which addressed Hodgkin lymphoma.

Dr Bollard is also a member of the Division of the Blood and Marrow Transplantation and senior scientist at the Children National Health System's Center for Cancer and Immunology Research at Children’s Research Institute. She is the Principal Investigator and the Sheikh Zayed Institute for Pediatric Surgical Innovation.

Showing 1 out of 2